Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • FCX vs GSK✓SelectedUSD · GSKFCX vs GSK performance historyLatest closeAs of-4.53%11/19
Stock and ETF performance explorer

FCX vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+37.5%
GSK return
+39.6%
Excess return
-2.1%
Maximum drawdown
-51.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.5%-1.6%-3.0%-4.1%
7D-18.7%-4.7%-14.0%-17.6%
30D-28.7%-4.7%-24.0%-27.8%
3M-28.8%-8.8%-20.0%-27.0%
6M-15.9%-4.6%-11.3%-15.4%
YTD-2.4%+1.0%-3.4%-3.8%
1Y+20.2%+6.9%+13.3%+16.3%
3Y+41.6%+52.5%-11.0%+14.8%
5Y+37.5%+40.3%-2.8%+6.7%
All+37.5%+39.6%-2.1%+6.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling